Prime Medicine, Inc. Quarterly Liabilities in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Prime Medicine, Inc. quarterly Liabilities history and growth rate from Q4 2021 to Q3 2024.
Prime Medicine, Inc. Liabilities for the quarter ending September 30, 2024 was $143M, a 217% increase year-over-year.

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$143M	+$98.1M	+217%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$63.1M	+$22.4M	+54.8%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$67.6M	+$29.5M	+77.3%	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$60.8M	+$16.7M	+38%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$45.2M	+$2.63M	+6.17%	Sep 30, 2023	10-Q	2023-11-03
Q2 2023	$40.8M			Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$38.1M			Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$44M	-$18.3M	-29.3%	Dec 31, 2022	10-K	2024-03-01
Q3 2022	$42.6M			Sep 30, 2022	10-Q	2022-11-14
Q4 2021	$62.3M			Dec 31, 2021	10-K	2023-03-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.